.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Novartis
QuintilesIMS
Express Scripts
Medtronic
Chinese Patent Office
Covington
Fish and Richardson
McKinsey
US Army

Generated: November 18, 2017

DrugPatentWatch Database Preview

URSO FORTE Drug Profile

« Back to Dashboard

What is the patent landscape for Urso Forte, and what generic Urso Forte alternatives are available?

Urso Forte is a drug marketed by Forest Labs Inc and is included in one NDA.

The generic ingredient in URSO FORTE is ursodiol. There are seven drug master file entries for this compound. Twenty-six suppliers are listed for this compound. Additional details are available on the ursodiol profile page.

Pharmacology for URSO FORTE

Ingredient-typeBile Acids and Salts
Drug ClassBile Acid
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Forest Labs Inc
URSO FORTE
ursodiol
TABLET;ORAL020675-002Jul 21, 2004ABRXYesYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: URSO FORTE

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Forest Labs Inc
URSO FORTE
ursodiol
TABLET;ORAL020675-002Jul 21, 2004► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Colorcon
Chinese Patent Office
Merck
Federal Trade Commission
Mallinckrodt
AstraZeneca
Daiichi Sankyo
Covington
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot